MPO and amyotrophic lateral sclerosis: The pathological role and cellular origin of MPO in the central nervous system of human ALS remains unclear.7 Our expectation of benefit from verdiperstat in ALS is derived from other neurodegenerative disorders with overlapping biological pathways such as neuroinflammation, oxidative stress, and autophagy, as well as preclinical data in ALS models.